Opal Biosciences’ anti-infective technology profiled at 2015 BIO International Convention June 17, 2015 • Category • Author Name

Latest News

• Company Update and EOFY 2018 Information

  August 3, 2018

  Infectious disease therapy and vaccine development company BioDiem Ltd and its subsidiary company Opal Biosciences Ltd (“Opal”) are pleased to provide the following information.

  Read More

• Opal Information Memorandum Announcement

  July 25, 2018

  Opal Biosciences Limited announces its Information Memorandum

  Read More